GridAI Technologies GRDX
NASDAQ GRDX
$2.97 -0.05 (-1.66%)
At close: Sep 10, 2026 · 4:00 PM EDT

GridAI Technologies (GRDX) Net Shares Issued and Repurchased (2017 - 2025)

GridAI Technologies' (GRDX) quarterly Net Shares Issued and Repurchased came in at $357.0 in Q4 2025, down 99.47% on a YoY basis from $66884.0 in Q4 2024, and down 92.86% quarter-over-quarter from $5000.0 in Q1 2025.

Analysis

GridAI Technologies (GRDX) Net Shares Issued and Repurchased (2017 - 2025) Analysis & Trends

GridAI Technologies (GRDX) has reported Net Shares Issued and Repurchased for 9 consecutive years, with $357.0 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Net Shares Issued and Repurchased fell 99.47% year-over-year to $357.0; the trailing twelve-month figure through Dec 2025 stood at $357.0 (down 99.47% YoY), and the FY2025 full-year result was $357.0, down 99.47% from the prior year.
  • Net Shares Issued and Repurchased declined to $357.0 in Q4 2025 per GRDX's latest filing, from $5000.0 in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at $200652.0 in Q1 2024 and bottomed at $153.0 in Q4 2022.
  • Historically, Net Shares Issued and Repurchased has averaged $36997.4 across 5 years, with a median of $5000.0 in 2023.
  • The sharpest annual moves came in 2021 and 2024: Net Shares Issued and Repurchased plunged 99.97% in 2021, then soared 12862.02% in 2024.
  • Over 5 years, Net Shares Issued and Repurchased stood at $825.0 in 2021, then plunged by 81.45% to $153.0 in 2022, then soared by 237.25% to $516.0 in 2023, then jumped by 12862.02% to $66884.0 in 2024, then sank by 99.47% to $357.0 in 2025.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $357.0, $5000.0, and $66884.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 GridAI Technologies 19.07 Mn 19.07 Mn -36,514.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 357.00
Mar 31, 2025 5,000.00
Dec 31, 2024 66,884.00
Mar 31, 2024 200,652.00
Dec 31, 2023 516.00
Mar 31, 2023 5,000.00
Dec 31, 2022 153.00
Mar 31, 2022 3,219.00
Dec 31, 2021 825.00
Jun 30, 2021 90,000.00
Mar 31, 2021 34,365.00
Dec 31, 2020 2.88 Mn
Jun 30, 2020 4,000.00
Mar 31, 2020 335,006.00
Dec 31, 2019 1.19 Mn
Dec 31, 2018 539,000.00
Dec 31, 2017 545,000.00
Mar 31, 2017 55,000.00